Passer au contenu
OTR3, Science for Regeneration
  • Qui sommes-nous ?
  • Notre technologie
    • Technologie des RGTA®
    • Pipeline
    • Publications
  • Nos engagements
  • Notre activité commerciale
    • Dispositif médical pour l’homme
      • Cacipliq 20®
    • Produits vétérinaires
      • Clerapliq®
      • Dermapliq® Spray
    • Cosmétique Sportive
  • Actualités
  • Contact
  • Français
    • Français
    • English

Latest Publications

  • October 2025 – Publication – Potential of Heparan Sulphate Mimetics Integrated Into Collagen Scaffolds for Enhanced Skin Wound Healing

    Latest Publications | News | RGTA technology

    Potential of Heparan Sulphate Mimetics Integrated Into Collagen Scaffolds for Enhanced Skin Wound Healing Nancy Avila-Martinez1 | Roman Krymchenko1 | Merel Gansevoort1 | Maren Pfirrmann1 | Sofia Aparicio1 | Agnes Choppin2 | Franck Chiappini2 | Denis Barritault2 | Martijn Verdoes1,3 | Toin H. van Kuppevelt1 | Bouke K. H. L. [...]

  • October 2025 -Exploring the Antifibrotic Potential of the heparan sulfate mimetic OTR4120: Insights from Preclinical Models

    Latest Publications | News | RGTA technology

    Exploring the Antifibrotic Potential of the heparan sulfate mimetic OTR4120: Insights from Preclinical Models Manuela Marega1,2,3, Najet Mejdoubi-Charef4 , David Wiegard1, Muzamil Majid Khan5,6, Marek Bartkuhn2, Laura Gambs2, Tara Procida-Kowalski2, Jochem Wilhelm2, Esmeralda Vasquez-Pacheco1, Afshin Noori1,2, Ying Dong1,2, Yi Zheng7, Xuran Chu7, Arun Lingampally1,2, Joanna Zukowska5,6, Said Charef8,9, Franck Chiappini8,9, [...]

  • October 2025 – Publication – Next-Generation Biomaterials for Wound Healing: Development and Evaluation of Collagen Scaffolds Functionalized with a Heparan Sulfate Mimic and Fibroblast Growth Factor 2

    Latest Publications | News | RGTA technology

    Next-Generation Biomaterials for Wound Healing: Development and Evaluation of Collagen Scaffolds Functionalized with a Heparan Sulfate Mimic and Fibroblast Growth Factor 2 Merel Gansevoort 1 , Sabine Wentholt 1, Gaia Li Vecchi 1, Marjolein de Vries 1, Elly M. M. Versteeg 1, Bouke K. H. L. Boekema 2,3 , Agnes [...]

  • October 2025 – Publication – Intra‑arterial Injection of OTR4132, a Novel Neuroprotector in Acute Ischemic Stroke: The MaTRISS Trial

    Latest Publications | Neuroprotection | News | RGTA technology

    Intra‑arterial Injection of OTR4132, a Novel Neuroprotector in Acute Ischemic Stroke: The MaTRISS Trial Xavier Barreau1 · René Anxionnat2 · Olivier Heck3 · Igor Sibon4,5 · Charlotte Rosso6 · Catherine Oppenheim7 · Francisco Moniche8 · Frédéric Sedel9 · Franck Chiappini9 · Agnès Choppin9 · Martin Inizan9 · Denis Barritault9 · [...]

  • November 2024 – Advances in In Vitro Modeling of Pulmonary Fibrosis: Focus on Precision-Cut Lung Slices (PCLS) Model

    Latest Publications | Lungs/Poumons | Media Publications | On-going research

    Hanan Osman-Ponchet (1) , Laurie Perdigon (1) , Manon Barthe (1) , Ines Metatla (2) , Kevin Rogers (2) , Ida Chiara Guerrera (2) , Franck Chiappini (3) , Agnes Choppin (3) Pulmonary fibrosis is a progressive lung disease characterized by scarring and stiffening of lung tissue, ultimately leading to [...]

OTR3, Science for Regeneration

Organes Tissus Régénération Réparation Remplacement

©2025 | OTR3 | All rights reserved.

  • Politique de confidentialité
  • Mentions légales
Kiwik, agence web à Orléans
Page load link
Aller en haut